Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Anticancer Research|January 4, 2012
Serum 25-hydroxyvitamin D levels in patients with vulvar cancerDarius Salehin, Christina Haugk, Marc Thill, et al.
Expert Opinion on Emerging Drugs|January 20, 2011
Emerging gonadotropin-releasing hormone agonistsDaniel Alexander Beyer, Feriel Amari, Marc Thill, et al.
British Journal of Cancer|May 6, 2020
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysisHolm Eggemann, Cosima Brucker, Michael Schrauder, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotopeMarc Thill, Andrzej Kurylcio, Rebekka Welter, et al.
Breast Care (Basel, Switzerland)|June 29, 2012
Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel DiscussionChristian Jackisch, Hans-Joachim Lück, Michael Untch, et al.
Breast (Edinburgh, Scotland)|July 29, 2014
Response to Barranger E, Ihrai T, response to the article by Thill et al.: "The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014, 23(2):175-9Marc Thill, Andrzej Kurylcio, Rebekka Welter, et al.
Archives of Gynecology and Obstetrics|August 23, 2011
Cancer in pregnancy. Part I: basic diagnostic and therapeutic principles and treatment of gynecological malignanciesFriederike Hoellen, Roland Reibke, Katrin Hornemann, et al.
Anticancer Research|January 29, 2018
Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell LinesMichael Friedrich, Kathrin Reichert, Alena Woeste, et al.
Archives of Gynecology and Obstetrics|August 23, 2011
Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignanciesFriederike Hoellen, Roland Reibke, Katrin Hornemann, et al.
Anticancer Research|July 23, 2011
In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancerSolveig Landt, Harald Heidecke, Susanne Korlach, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Anticancer Research|January 4, 2012
Serum 25-hydroxyvitamin D levels in patients with vulvar cancerDarius Salehin, Christina Haugk, Marc Thill, et al.
Expert Opinion on Emerging Drugs|January 20, 2011
Emerging gonadotropin-releasing hormone agonistsDaniel Alexander Beyer, Feriel Amari, Marc Thill, et al.
British Journal of Cancer|May 6, 2020
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysisHolm Eggemann, Cosima Brucker, Michael Schrauder, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotopeMarc Thill, Andrzej Kurylcio, Rebekka Welter, et al.
Breast Care (Basel, Switzerland)|June 29, 2012
Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel DiscussionChristian Jackisch, Hans-Joachim Lück, Michael Untch, et al.
Breast (Edinburgh, Scotland)|July 29, 2014
Response to Barranger E, Ihrai T, response to the article by Thill et al.: "The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014, 23(2):175-9Marc Thill, Andrzej Kurylcio, Rebekka Welter, et al.
Archives of Gynecology and Obstetrics|August 23, 2011
Cancer in pregnancy. Part I: basic diagnostic and therapeutic principles and treatment of gynecological malignanciesFriederike Hoellen, Roland Reibke, Katrin Hornemann, et al.
Anticancer Research|January 29, 2018
Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell LinesMichael Friedrich, Kathrin Reichert, Alena Woeste, et al.
Archives of Gynecology and Obstetrics|August 23, 2011
Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignanciesFriederike Hoellen, Roland Reibke, Katrin Hornemann, et al.
Anticancer Research|July 23, 2011
In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancerSolveig Landt, Harald Heidecke, Susanne Korlach, et al.
Pageof 17